Cargando…

Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst

BACKGROUND AND PURPOSE: Telangiectatic osteosarcoma (TOS), a rare variant of osteosarcoma, may be easily misdiagnosed as aneurysmal bone cyst (ABC). The aims of this study were to investigate the diagnostic and prognostic factors of TOS by reviewing our experience with TOS and to develop a diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jun-qiang, Fu, Yi-wei, Xie, Xian-biao, Cheng, Xiao-yu, Yang, Xiao-yu, Liu, Wei-hai, Tu, Jian, Gao, Zhen-hua, Shen, Jing-nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993956/
https://www.ncbi.nlm.nih.gov/pubmed/29892520
http://dx.doi.org/10.1016/j.jbo.2017.11.003
_version_ 1783330323653722112
author Yin, Jun-qiang
Fu, Yi-wei
Xie, Xian-biao
Cheng, Xiao-yu
Yang, Xiao-yu
Liu, Wei-hai
Tu, Jian
Gao, Zhen-hua
Shen, Jing-nan
author_facet Yin, Jun-qiang
Fu, Yi-wei
Xie, Xian-biao
Cheng, Xiao-yu
Yang, Xiao-yu
Liu, Wei-hai
Tu, Jian
Gao, Zhen-hua
Shen, Jing-nan
author_sort Yin, Jun-qiang
collection PubMed
description BACKGROUND AND PURPOSE: Telangiectatic osteosarcoma (TOS), a rare variant of osteosarcoma, may be easily misdiagnosed as aneurysmal bone cyst (ABC). The aims of this study were to investigate the diagnostic and prognostic factors of TOS by reviewing our experience with TOS and to develop a diagnostic model that may distinguish TOS from ABC. MATERIALS AND METHODS: We identified 51 cases of TOS treated at the First Affiliated Hospital of Sun Yat-Sen University from March 2001 to January 2016 and reviewed their records, imaging information and pathological studies. A diagnostic model was developed to differentiate TOS and ABC by Bayes discriminant analysis and was evaluated. The log-rank test was used to analyze the prognostic factors of TOS and to compare the outcome differences between TOS and other high-grade osteosarcoma subtypes. RESULTS: The multi-disciplinary diagnostic method employed that combined clinical, imaging, and pathological studies enhanced the diagnostic accuracy. Age 18 years or younger and pathologic fracture were more common among the TOS patients than among the ABC patients (P = .004 and .005, respectively). The average white blood cell (WBC), platelet, lactate dehydrogenase (LDH), and alkaline phosphatase (ALP) values of the TOS patients were higher than those of the ABC patients (P = .002, .003, .007, and .007, respectively). Our diagnostic model, including the aforementioned factors, accurately predicted 62% and 78% of the TOS patients in the training and validation sets, respectively. The 5-year estimates of event-free survival and overall survival of the TOS patients were 52.5 ± 9.4% and 54.9 ± 8.8%, respectively, which were similar to those of patients with other osteosarcoma subtypes (P = .950 and .615, respectively). Tumor volume and the LDH level were predictive prognostic factors (P = .040 and .044) but not the presence of pathologic fracture or misdiagnosis (P = .424 and .632, all respectively). CONCLUSIONS: The multi-disciplinary diagnostic method and diagnostic model based on predictive factors, i.e., age, the presence of pathologic fracture, and platelet, LDH, ALP and WBC levels, aided the differentiation of TOS and ABC. Smaller tumors and normal LDH levels were associated with better outcomes.
format Online
Article
Text
id pubmed-5993956
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59939562018-06-11 Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst Yin, Jun-qiang Fu, Yi-wei Xie, Xian-biao Cheng, Xiao-yu Yang, Xiao-yu Liu, Wei-hai Tu, Jian Gao, Zhen-hua Shen, Jing-nan J Bone Oncol Research Article BACKGROUND AND PURPOSE: Telangiectatic osteosarcoma (TOS), a rare variant of osteosarcoma, may be easily misdiagnosed as aneurysmal bone cyst (ABC). The aims of this study were to investigate the diagnostic and prognostic factors of TOS by reviewing our experience with TOS and to develop a diagnostic model that may distinguish TOS from ABC. MATERIALS AND METHODS: We identified 51 cases of TOS treated at the First Affiliated Hospital of Sun Yat-Sen University from March 2001 to January 2016 and reviewed their records, imaging information and pathological studies. A diagnostic model was developed to differentiate TOS and ABC by Bayes discriminant analysis and was evaluated. The log-rank test was used to analyze the prognostic factors of TOS and to compare the outcome differences between TOS and other high-grade osteosarcoma subtypes. RESULTS: The multi-disciplinary diagnostic method employed that combined clinical, imaging, and pathological studies enhanced the diagnostic accuracy. Age 18 years or younger and pathologic fracture were more common among the TOS patients than among the ABC patients (P = .004 and .005, respectively). The average white blood cell (WBC), platelet, lactate dehydrogenase (LDH), and alkaline phosphatase (ALP) values of the TOS patients were higher than those of the ABC patients (P = .002, .003, .007, and .007, respectively). Our diagnostic model, including the aforementioned factors, accurately predicted 62% and 78% of the TOS patients in the training and validation sets, respectively. The 5-year estimates of event-free survival and overall survival of the TOS patients were 52.5 ± 9.4% and 54.9 ± 8.8%, respectively, which were similar to those of patients with other osteosarcoma subtypes (P = .950 and .615, respectively). Tumor volume and the LDH level were predictive prognostic factors (P = .040 and .044) but not the presence of pathologic fracture or misdiagnosis (P = .424 and .632, all respectively). CONCLUSIONS: The multi-disciplinary diagnostic method and diagnostic model based on predictive factors, i.e., age, the presence of pathologic fracture, and platelet, LDH, ALP and WBC levels, aided the differentiation of TOS and ABC. Smaller tumors and normal LDH levels were associated with better outcomes. Elsevier 2017-11-26 /pmc/articles/PMC5993956/ /pubmed/29892520 http://dx.doi.org/10.1016/j.jbo.2017.11.003 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Yin, Jun-qiang
Fu, Yi-wei
Xie, Xian-biao
Cheng, Xiao-yu
Yang, Xiao-yu
Liu, Wei-hai
Tu, Jian
Gao, Zhen-hua
Shen, Jing-nan
Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
title Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
title_full Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
title_fullStr Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
title_full_unstemmed Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
title_short Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
title_sort telangiectatic osteosarcoma: outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993956/
https://www.ncbi.nlm.nih.gov/pubmed/29892520
http://dx.doi.org/10.1016/j.jbo.2017.11.003
work_keys_str_mv AT yinjunqiang telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT fuyiwei telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT xiexianbiao telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT chengxiaoyu telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT yangxiaoyu telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT liuweihai telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT tujian telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT gaozhenhua telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst
AT shenjingnan telangiectaticosteosarcomaoutcomeanalysesandadiagnosticmodelfordifferentiationfromaneurysmalbonecyst